W
Wuhan Landing Medical High Technology
Wuhan Landing Medical High Technology is a scientific and technological company
About Wuhan Landing Medical High Technology
Wuhan Landing Medical High-tech Co., Ltd. operates at the intersection of artificial intelligence and pathology to advance early cancer detection. Founded in 2000 by Dr. Xiaorong Sun, the company focuses on creating accessible and affordable diagnostic solutions. Dr. Sun's journey began in 1996 during a research fellowship in Canada where she first encountered digital pathology. Inspired to address the scarcity of pathologists and uneven distribution of healthcare resources in China, she returned in 2001 to launch the company, aiming to make cancer screening widely available and data-driven. After a significant early setback involving a failed partnership, Dr. Sun rebuilt the company, concentrating on developing proprietary AI and medical hardware.
The firm's core business revolves around an AI-powered platform for remote digital pathology analysis, with a primary application in cervical cancer screening. This system utilizes automation, cloud computing, and AI to digitize and analyze cell samples, flagging suspicious cells for review by cytopathologists. This significantly enhances efficiency, allowing one of the company's robots to screen at least 35,000 samples a day compared to the 100 a doctor can screen manually. The business model targets governments, hospitals, and laboratories, providing them with the technology to conduct large-scale screening programs. Revenue is generated through the sale of these AI-powered systems and services, which include slide preparation machines, liquid-based cytology consumables, and digital slide scanners. The company has successfully completed over 10 million AI-assisted cervical cancer screenings.
A key milestone was achieved in 2017 when the company began integrating its technologies into Pap smear testing across China. This led to its selection by the Hubei Provincial Health Commission in 2022 for a massive screening initiative covering over 12 million women. The company has secured approximately $50.1 million in funding over three rounds, with its latest Series D round in November 2021. Investors include Bank of China Group Investment and Alibaba Health Information Technology. Landing Med's technology has gained approvals for marketing in the US, EU, and China and is being implemented in countries like Pakistan, Malaysia, and Indonesia as part of the "Belt and Road Initiative".
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | Nov 2021 | $44M | $176M | Ether Capital · AliHealth | — |
| SERIES C✓Equity / VC | Oct 2018 | — | — | China Merchants Capital · Bank of China Hong Kong | — |
Growth signals
Latest recorded traffic for Wuhan Landing Medical High Technology is 620 monthly website visits, down 21.5% over the last three months. Wuhan Landing Medical High Technology's team grew 40% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Wuhan Landing Medical High Technology in the Wuhan ecosystem
The Wuhan Landing Medical High Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Sangel Capital- DVDalton Venture
Series B and later4 investors entered at this stage
- CCChina Merchants Capital
Bank of China Hong Kong
AliHealth- ECEther Capital
Other known investors1 additional known investor
BC Cancer Agency
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Wuhan Landing Medical High Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Wuhan Landing Medical High Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










